Protein kinase C inhibitor chelerythrine attenuates the morphine-induced excitatory amino acid release and reduction of the antinociceptive effect of morphine in rats injected intrathecally with pertussis toxin

Gong-Jhe Wu, Zhi Hong Wen, Yi Chen Chang, San Nan Yang, Pao Luh Tao, Chih Shung Wong

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Neuropathic pain syndromes respond poorly to opioid treatment. In our previous studies, we found that intrathecal (i.t.) injection of pertussis toxin (PTX) produces thermal hyperalgesia, which is poorly responsive to morphine and is accompanied by an increase in cerebrospinal fluid (CSF) levels of excitatory amino acids (EAAs) and protein kinase C (PKC) activation. In the present study, rats were implanted with an i.t. catheter for drug injection and a microdialysis probe for CSF dialysate collection. On the fourth day after injection of PTX (2 μg, i.t.), there was a significant reduction in the antinociceptive effect of morphine (10 μg, i.t.) which was accompanied by an increase in levels of EAAs. Pretreatment with the PKC inhibitor, chelerythrine (25 μg, i.t.) one hour before morphine injection markedly inhibited both effects. These results suggest that, in PTX-treated rats, PKC plays an important role in inhibiting the morphine-induced spinal EAA release, which might be related to the reduced antinociceptive effect of morphine.

Original languageEnglish
Pages (from-to)1801-1807
Number of pages7
JournalLife Sciences
Volume78
Issue number16
DOIs
Publication statusPublished - Mar 13 2006
Externally publishedYes

Fingerprint

Excitatory Amino Acids
Protein C Inhibitor
Pertussis Toxin
Protein Kinase Inhibitors
Morphine
Protein Kinase C
Rats
Cerebrospinal fluid
Injections
Cerebrospinal Fluid
Spinal Injections
Catheters
Dialysis Solutions
Hyperalgesia
Microdialysis
Neuralgia
Opioid Analgesics
Chemical activation
chelerythrine
Pharmaceutical Preparations

Keywords

  • Excitatory amino acids
  • Morphine
  • Pertussis toxin
  • Protein kinase C

ASJC Scopus subject areas

  • Pharmacology

Cite this

Protein kinase C inhibitor chelerythrine attenuates the morphine-induced excitatory amino acid release and reduction of the antinociceptive effect of morphine in rats injected intrathecally with pertussis toxin. / Wu, Gong-Jhe; Wen, Zhi Hong; Chang, Yi Chen; Yang, San Nan; Tao, Pao Luh; Wong, Chih Shung.

In: Life Sciences, Vol. 78, No. 16, 13.03.2006, p. 1801-1807.

Research output: Contribution to journalArticle

@article{dfaaf6af939e4e96b5eb3e0f94db5543,
title = "Protein kinase C inhibitor chelerythrine attenuates the morphine-induced excitatory amino acid release and reduction of the antinociceptive effect of morphine in rats injected intrathecally with pertussis toxin",
abstract = "Neuropathic pain syndromes respond poorly to opioid treatment. In our previous studies, we found that intrathecal (i.t.) injection of pertussis toxin (PTX) produces thermal hyperalgesia, which is poorly responsive to morphine and is accompanied by an increase in cerebrospinal fluid (CSF) levels of excitatory amino acids (EAAs) and protein kinase C (PKC) activation. In the present study, rats were implanted with an i.t. catheter for drug injection and a microdialysis probe for CSF dialysate collection. On the fourth day after injection of PTX (2 μg, i.t.), there was a significant reduction in the antinociceptive effect of morphine (10 μg, i.t.) which was accompanied by an increase in levels of EAAs. Pretreatment with the PKC inhibitor, chelerythrine (25 μg, i.t.) one hour before morphine injection markedly inhibited both effects. These results suggest that, in PTX-treated rats, PKC plays an important role in inhibiting the morphine-induced spinal EAA release, which might be related to the reduced antinociceptive effect of morphine.",
keywords = "Excitatory amino acids, Morphine, Pertussis toxin, Protein kinase C",
author = "Gong-Jhe Wu and Wen, {Zhi Hong} and Chang, {Yi Chen} and Yang, {San Nan} and Tao, {Pao Luh} and Wong, {Chih Shung}",
year = "2006",
month = "3",
day = "13",
doi = "10.1016/j.lfs.2005.08.020",
language = "English",
volume = "78",
pages = "1801--1807",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Protein kinase C inhibitor chelerythrine attenuates the morphine-induced excitatory amino acid release and reduction of the antinociceptive effect of morphine in rats injected intrathecally with pertussis toxin

AU - Wu, Gong-Jhe

AU - Wen, Zhi Hong

AU - Chang, Yi Chen

AU - Yang, San Nan

AU - Tao, Pao Luh

AU - Wong, Chih Shung

PY - 2006/3/13

Y1 - 2006/3/13

N2 - Neuropathic pain syndromes respond poorly to opioid treatment. In our previous studies, we found that intrathecal (i.t.) injection of pertussis toxin (PTX) produces thermal hyperalgesia, which is poorly responsive to morphine and is accompanied by an increase in cerebrospinal fluid (CSF) levels of excitatory amino acids (EAAs) and protein kinase C (PKC) activation. In the present study, rats were implanted with an i.t. catheter for drug injection and a microdialysis probe for CSF dialysate collection. On the fourth day after injection of PTX (2 μg, i.t.), there was a significant reduction in the antinociceptive effect of morphine (10 μg, i.t.) which was accompanied by an increase in levels of EAAs. Pretreatment with the PKC inhibitor, chelerythrine (25 μg, i.t.) one hour before morphine injection markedly inhibited both effects. These results suggest that, in PTX-treated rats, PKC plays an important role in inhibiting the morphine-induced spinal EAA release, which might be related to the reduced antinociceptive effect of morphine.

AB - Neuropathic pain syndromes respond poorly to opioid treatment. In our previous studies, we found that intrathecal (i.t.) injection of pertussis toxin (PTX) produces thermal hyperalgesia, which is poorly responsive to morphine and is accompanied by an increase in cerebrospinal fluid (CSF) levels of excitatory amino acids (EAAs) and protein kinase C (PKC) activation. In the present study, rats were implanted with an i.t. catheter for drug injection and a microdialysis probe for CSF dialysate collection. On the fourth day after injection of PTX (2 μg, i.t.), there was a significant reduction in the antinociceptive effect of morphine (10 μg, i.t.) which was accompanied by an increase in levels of EAAs. Pretreatment with the PKC inhibitor, chelerythrine (25 μg, i.t.) one hour before morphine injection markedly inhibited both effects. These results suggest that, in PTX-treated rats, PKC plays an important role in inhibiting the morphine-induced spinal EAA release, which might be related to the reduced antinociceptive effect of morphine.

KW - Excitatory amino acids

KW - Morphine

KW - Pertussis toxin

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=33644503887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644503887&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2005.08.020

DO - 10.1016/j.lfs.2005.08.020

M3 - Article

VL - 78

SP - 1801

EP - 1807

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 16

ER -